Showing results (171-180 of 941) with videos related to
Sort By:
Pageof 95
Diabetes & Vascular Disease Research|March 4, 2018
In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR-/-ApoB100/100 miceFabiana Blanco, Suvi E Heinonen, Erika Gurzeler, et al.Diabetes & Vascular Disease Research|March 1, 2018
Long-term changes in retinal vascular diameter and cognitive impairment in type 1 diabetesKaren A Nunley, Andrea L Metti, Ronald Klein, et al.Diabetes & Vascular Disease Research|April 18, 2012
Primary and secondary prevention of cardiovascular disease in diabetes with aspirinOliver Schnell, Michael Erbach, Michael HummelDiabetes & Vascular Disease Research|May 19, 2018
Detection of perimacular red dots and blots when screening for diabetic retinopathy: Refer or not refer?Anatolie Baltatescu, Elio Striglia, Marina Trento, et al.Diabetes & Vascular Disease Research|June 10, 2017
Percutaneous closure of the left atrial appendage in patients with diabetes mellitusObayda Azizy, Christos Rammos, Nils Lehmann, et al.Diabetes & Vascular Disease Research|July 20, 2018
Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic ratsIrina Filchenko, Anna Simanenkova, Svetlana Chefu, et al.Diabetes & Vascular Disease Research|November 24, 2005
Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetesAndrew F B Kernohan, Angela Spiers, Naveed Sattar, et al.Diabetes & Vascular Disease Research|November 25, 2005
The metabolic syndrome: one step forward, two steps backSun H Kim, Gerald M ReavenDiabetes & Vascular Disease Research|November 25, 2005
Pioglitazone plus a sulphonylurea or metformin is associated with increased lipoprotein particle size in patients with type 2 diabetesAlfonso Perez, Mehmood Khan, Todd Johnson, et al.Diabetes & Vascular Disease Research|November 25, 2005
Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetesMensud Hatunic, Nicole Burns, Francis Finucane, et al.Pageof 95